Vanguard European Stock Index Fund Investor Shares VEURX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 46.83  /  −2.03 %
  • Total Assets 38.1B
  • Adj. Expense Ratio
    0.230%
  • Expense Ratio 0.230%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Europe Stock
  • Investment Style Large Blend
  • Min. Initial Investment 0
  • Status Limited
  • TTM Yield 2.62%
  • Turnover 5%

USD | NAV as of Jun 06, 2026 | 1-Day Return as of Jun 06, 2026, 2:33 AM GMT+0

unlocked

Morningstar’s Analysis VEURX

Medalist rating as of .

A great option for diverse European stock exposure.

Our research team assigns Gold ratings to strategies that they have the most conviction will outperform their Morningstar Category average over a market cycle on a risk-adjusted basis.

A great option for diverse European stock exposure.

Associate Analyst Brian  Paoli

Brian Paoli

Associate Analyst

Summary

Vanguard FTSE Europe ETF collects stocks from numerous developed European countries.

This fund tracks the FTSE Developed Europe All Cap Index, which targets large-, mid-, and small-cap stocks across developed countries in Europe. Market-cap weighting naturally reduces turnover and trading costs by channeling the market’s collective opinion of a stock’s relative value. This means stocks that do well take up a greater share of the portfolio, which can sometimes concentrate the fund in expensive stocks or market segments that have done especially well.

Country exposure has evolved with Europe’s shifting landscape. Since launching in 2005, the fund’s UK allocation has declined to about 22% from over 36% by the end of January 2026. This decline reflects the weaker relative performance of UK stocks, a trend shared across Morningstar Category peers. Even so, the UK remains the fund’s largest single-country weighting, which is also consistent with broad European benchmarks.

The fund’s inclusion of small-cap stocks creates only modest differences relative to peers. Market-cap weighting still anchors the portfolio in Europe’s largest companies. Sector weightings also closely resemble the category norm, favoring large companies across healthcare, financials, and industrials.

The fund holds materially less cash than its average peer, which fully exposes it to market movements. This lower cash buffer increases day-to-day volatility, but it also allows the fund to experience higher highs and lower lows through different environments.

Long-term performance has been strong. The US ETF share class outperformed the Europe stock category average by 65 basis points annualized since changing its index in 2015 and through January 2026. Its low fee and broad diversification supported this advantage and present a durable edge over peers moving forward.

Rated on Published on

Associate Analyst Brian  Paoli

Brian Paoli

Associate Analyst

Process

High

This strategy efficiently allocates across more than 1,000 stocks in numerous developed European markets, earning it a High Process Pillar rating.

Managers replicate the FTSE Developed Europe All Cap Index, maintaining a portfolio of over 1,200 stocks that mimics the performance and risk characteristics of its index.

The FTSE Developed Europe All Cap Index invests in stocks of all sizes across 16 developed countries. It is derived from the FTSE Global Equity Index series, which captures the top 98% of the world’s investable market capitalization. Included stocks are weighted by market cap, which helps mitigate turnover and trading costs. Investability screens and buffers are used to further limit turnover and trading costs, which regularly run less than 5% annually, far lower than many peers. The index is rebalanced semiannually in March and September.

Country allocations closely mirror the category average, though the category itself has evolved. The UK has consistently represented the fund’s largest country exposure since inception. Its weight has declined, however, to 22% at the end of January 2026 from more than 36% at the fund’s 2005 launch. Other countries’ weightings have remained stable or grown modestly, a pattern that aligns with broader trends across the Europe stock category.

Sector exposures also closely mirror the category norm. Financials, industrials, and healthcare together account for more than 57% of the portfolio, and the fund avoids any meaningful over- or underweightings relative to peers. This means financials, industrials, and healthcare companies will generally steer category returns, and the fund should rarely deviate substantially from the norm, allowing its low fee to carve a durable advantage over higher-cost peers.

Small- and mid-cap exposure distinguishes the fund. It overweights each segment by more than 2 percentage points compared with the category, which results in a slight underweight position to the largest European companies. Even so, European heavyweights such as ASML, Roche, and AstraZeneca still occupy prominent positions among the fund’s top holdings. Added breadth should help stabilize returns when the largest companies falter.

Rated on Published on

Associate Analyst Brian  Paoli

Brian Paoli

Associate Analyst

People

Above Average

Vanguard's equity index group earns an Above Average People Pillar for its well-supported and stable management team adept at leveraging Vanguard's comprehensive resources. Its portfolio managers benefit from the firm's global infrastructure and advanced portfolio management technology, which facilitates cost-efficient trading around the globe. The infrequent turnover of managers, coupled with Vanguard's practice of rotating them across various funds, enhances their expertise and understanding of different market segments.

The fund's managers directly handle trading, providing them with deeper insights into the portfolio's operations than a stand-alone trader might have. They are backed by a global team of dedicated personnel and employ sophisticated, scalable technology to minimize their workload and enhance tracking accuracy. Vanguard's independent risk-management team plays a crucial role in ensuring its funds adhere to predetermined tracking tolerances. It collaborates closely with the managers to oversee trades and address potential issues proactively. Vanguard compensates managers based on tracking error and excess return metrics to foster a culture of accountability and ensure that the management team's interests are closely tied to those of investors.

Rated on Published on

Senior Analyst Daniel Sotiroff

Daniel Sotiroff

Senior Analyst

Parent

High

Vanguard maintains its High Parent Pillar rating as it continues to grow under new leadership.

CEO Salim Ramji has had a busy first year captaining Vanguard’s crew, and the ship remains pointed in the right direction. The firm made its largest round of fee cuts in early 2025, which came at an estimated cost of USD 350 million. It established a separate division dedicated to its advice and wealth management efforts, a sign that it wants to seriously compete within those lines of business. Asset growth has continued to be a huge success. Only BlackRock’s inflows rival the money Vanguard is taking in. Likewise, the number of clients it serves has more than doubled since 2015.

Despite that success, an ever-growing number of clients has presented a challenge: Vanguard can’t grow its services fast enough to keep up with demand. In some instances, it has had to curb certain services and capabilities or raise fees on others to cope, causing some loyal clients to criticize what they perceive as deteriorating services.

Vanguard has ambitions to bring its disruptive legacy to the bond market. It created roughly a dozen low-cost bond exchange-traded funds for US investors and several others abroad over the 12 months through June 2025. All have low fees in their respective categories, and the actively managed strategies align with Vanguard’s philosophy. They are relatively easy to understand and are conservatively managed.

Vanguard has another opportunity to prove that clients are still its priority. On the surface, its endeavor into the high-fee deal-making world of private assets alongside Wellington and Blackstone looks like a cultural mismatch. So far, the collaboration hasn’t produced anything that’s concerning.

Rated on Published on

Associate Analyst Brian  Paoli

Brian Paoli

Associate Analyst

Performance

The fund accurately represents European stock market performance. Its annualized return of 9.15% beat the category average by 65 basis points annualized since changing its index in September of 2015 through January 2026.

Sector and country exposures that closely align with the category norm allow the fund’s low fee to carve out an advantage. It also maintains a significantly lower cash position than the average fund in its category, which increases volatility relative to the norm but enables full participation in market rallies. The fund tends to capture more of the category norm’s upside and downside throughout market cycles.

European stocks delivered strong results in 2025, and the fund fully participated in that strength, benefiting from its broad market exposure, low fee, and fully invested portfolio. It was the fund’s best year in the past decade, returning 35.44% in 2025, outpacing its average category peer by 2.33 percentage points.

Published on

Associate Analyst Brian  Paoli

Brian Paoli

Associate Analyst

Price

1.62

Vanguard European Stock Investor's Prospectus Adjusted Expense Ratio is 0.23% per year. It places it in the cheapest quintile of the Morningstar US Fund Europe Stock Category, where the median fee is 0.69% per year. This cost positioning translates into a Medalist Rating Price Score of 1.62, which reflects its relative price positioning within the category. The Price Score ranges from -2.50 (most expensive) to +2.50 (cheapest), with higher scores indicating better cost competitiveness.

Published on

Portfolio Holdings VEURX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 18.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

ASML Holding NV

3.60 1B
Technology

HSBC Holdings PLC

2.03 769M
Financial Services

Roche Holding AG Ordinary Shares new

1.84 696M
Healthcare

AstraZeneca PLC

1.82 692M
Healthcare

Novartis AG Registered Shares

1.82 690M
Healthcare

Nestle SA

1.67 634M
Consumer Defensive

Shell PLC

1.66 629M
Energy

Siemens AG

1.40 531M
Industrials

Banco Santander SA

1.15 435M
Financial Services

Allianz SE

1.12 423M
Financial Services

Sponsor Center